Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-005500

Director sold 29,350 shares at an average $84.77 ($2,487,966)

  • Director acquired 29,350 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-02 Exercise or conversion : show line 1 in the form 10b5-1 +29,350 $36.75 $1,078,613 33,835.82 D
2024-05-02 Sale : show line 2 in the form 10b5-1 −12,207 $85.02 $1,037,839 21,628.82 D
2024-05-02 Sale : show line 3 in the form 10b5-1 −17,143 $84.59 $1,450,126 4,485.82 D
Open-market sales · 29,350 sh · avg $84.77 · $2,487,966

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-02 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −29,350 0 D
Loading xslF345X05/doc4.xml…